Compare INO & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INO | RFIL |
|---|---|---|
| Founded | 1979 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 99.5M |
| IPO Year | 1999 | 1996 |
| Metric | INO | RFIL |
|---|---|---|
| Price | $1.55 | $10.54 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $9.00 | ★ $11.25 |
| AVG Volume (30 Days) | ★ 647.3K | 312.6K |
| Earning Date | 03-12-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.18 | ★ 101.59 |
| EPS | N/A | ★ N/A |
| Revenue | $42,220,086.00 | ★ $55,325,000.00 |
| Revenue This Year | $24,407.60 | $7.07 |
| Revenue Next Year | $331.40 | $8.97 |
| P/E Ratio | ★ N/A | $1,203.00 |
| Revenue Growth | ★ 19.37 | 10.22 |
| 52 Week Low | $1.30 | $3.39 |
| 52 Week High | $2.86 | $13.54 |
| Indicator | INO | RFIL |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 48.15 |
| Support Level | $1.48 | $6.32 |
| Resistance Level | $1.60 | $12.69 |
| Average True Range (ATR) | 0.07 | 1.28 |
| MACD | -0.02 | -0.13 |
| Stochastic Oscillator | 6.25 | 25.80 |
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company has one operating segment. The company operates in Canada, Germany, China, the USA, and the United Kingdom, and Others.